• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 - 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Material
o Market segments
o Comparison by Material
o Glass pre-filled syringes - Market size and forecast 2019-2024
o Plastic pre-filled syringes - Market size and forecast 2019-2024
o Market opportunity by Material
• Market Segmentation by Application
o Insulin pre-filled syringes
o Vaccine pre-filled syringes
o Anticoagulant pre-filled syringes
o Others
• Market Segmentation by End-user
o Hospitals and clinics
o Home healthcare
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o Europe - Market size and forecast 2019-2024
o North America - Market size and forecast 2019-2024
o APAC - Market size and forecast 2019-2024
o ROW - Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Volume drivers - Demand led growth
o Volume driver - External factors
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Baxter International Inc.
o Recipharm AB
o Fresenius SE & Co. KGaA
o Medtronic Plc
o Mylan NV
o Nipro Corp.
o Novartis AG
o SCHOTT AG
o Terumo Corp.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2019 - 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 - 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2019
• 21: Glass pre-filled syringes - Market size and forecast 2019-2024 ($ million)
• 22: Glass pre-filled syringes - Year-over-year growth 2019-2024 (%)
• 23: Plastic pre-filled syringes - Market size and forecast 2019-2024 ($ million)
• 24: Plastic pre-filled syringes - Year-over-year growth 2019-2024 (%)
• 25: Customer landscape
• 26: Impact of drivers and challenges
• 27: Vendor landscape
• 28: Landscape disruption
• 29: Industry risks
• 30: Vendors covered
• 31: Market positioning of vendors
• 32: Baxter International Inc. - Overview
• 33: Baxter International Inc. - Business segments
• 34: Baxter International Inc. - Key offerings
• 35: Baxter International Inc. - Key customers
• 36: Baxter International Inc. - Segment focus
• 37: Becton, Dickinson and Co. - Overview
• 38: Becton, Dickinson and Co. - Business segments
• 39: Becton, Dickinson and Co. - Key offerings
• 40: Becton, Dickinson and Co. - Key customers
• 41: Becton, Dickinson and Co. - Segment focus
• 42: Recipharm AB - Overview
• 43: Recipharm AB - Business segments
• 44: Recipharm AB - Key offerings
• 45: Recipharm AB - Key customers
• 46: Recipharm AB - Segment focus
• 47: Fresenius SE & Co. KGaA - Overview
• 48: Fresenius SE & Co. KGaA - Business segments
• 49: Fresenius SE & Co. KGaA - Key offerings
• 50: Fresenius SE & Co. KGaA - Key customers
• 51: Fresenius SE & Co. KGaA - Segment focus
• 52: Medtronic Plc - Overview
• 53: Medtronic Plc - Business segments
• 54: Medtronic Plc - Key offerings
• 55: Medtronic Plc - Key customers
• 56: Medtronic Plc - Segment focus
• 57: Mylan NV - Overview
• 58: Mylan NV - Business segments
• 59: Mylan NV - Key offerings
• 60: Mylan NV - Key customers
• 61: Mylan NV - Segment focus
• 62: Nipro Corp. - Overview
• 63: Nipro Corp. - Business segments
• 64: Nipro Corp. - Key offerings
• 65: Nipro Corp. - Key customers
• 66: Nipro Corp. - Segment focus
• 67: Novartis AG - Overview
• 68: Novartis AG - Business segments
• 69: Novartis AG - Key offerings
• 70: Novartis AG - Key customers
• 71: Novartis AG - Segment focus
• 72: SCHOTT AG - Overview
• 73: SCHOTT AG - Business segments
• 74: SCHOTT AG - Key offerings
• 75: SCHOTT AG - Key customers
• 76: SCHOTT AG - Segment focus
• 77: Terumo Corp. - Overview
• 78: Terumo Corp. - Business segments
• 79: Terumo Corp. - Key offerings
• 80: Terumo Corp. - Key customers
• 81: Terumo Corp. - Segment focus
• 82: Currency conversion rates for US$
• 83: Research Methodology
• 84: Validation techniques employed for market sizing
• 85: Information sources
• 86: List of abbreviations

Companies Mentioned
• Baxter International Inc.
• Becton
• Dickinson and Co.
• Recipharm AB
• Fresenius SE & Co. KGaA
• Medtronic Plc
• Mylan NV
• Nipro Corp.
• Novartis AG
• SCHOTT AG
• Terumo Corp.